Filing Details
- Accession Number:
- 0001104659-16-163806
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-12-23 18:03:40
- Reporting Period:
- 2016-10-24
- Filing Date:
- 2016-12-23
- Accepted Time:
- 2016-12-23 18:03:40
- Original Submission Date:
- 2016-10-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1674416 | Crispr Therapeutics Ag | CRSP | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456590 | Versant Venture Capital Iv, L.p. | One Sansome Street, Suite 3630 San Francisco CA 94104 | No | No | Yes | No | |
| 1456591 | Versant Side Fund Iv, L.p. | One Sansome Street, Suite 3630 San Francisco CA 94104 | No | No | Yes | No | |
| 1589095 | Versant Affiliates Fund V, L.p. | One Sansome Street, Suite 3630 San Francisco CA 94104 | No | No | Yes | No | |
| 1589097 | Versant Venture Capital V, L.p. | One Sansome Street, Suite 3630 San Francisco CA 94104 | No | No | Yes | No | |
| 1589098 | Versant Ophthalmic Affiliates I, L.p. | One Sansome Street, Suite 3630 San Francisco CA 94104 | No | No | Yes | No | |
| 1612235 | Versant Venture Capital V (Canada), Lp | One Sansome Street, Suite 3630 San Francisco CA 94104 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-10-24 | 437,247 | $0.00 | 676,895 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 3,100,477 | $0.00 | 3,777,372 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 231,077 | $0.00 | 4,008,449 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 95,596 | $14.00 | 4,104,045 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 2,754 | $0.00 | 2,754 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 19,524 | $0.00 | 22,278 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 1,454 | $0.00 | 23,732 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 602 | $14.00 | 24,334 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 2,210,417 | $0.00 | 2,210,417 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 173,167 | $0.00 | 2,383,584 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 60,219 | $14.00 | 2,443,803 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 66,490 | $0.00 | 66,490 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 5,210 | $0.00 | 71,700 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 168,224 | $0.00 | 168,224 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 13,180 | $0.00 | 181,404 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 4,583 | $14.00 | 185,987 | No | 4 | P | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 73,704 | $0.00 | 73,704 | No | 4 | C | Indirect | Footnote |
| Common Stock | Acquisiton | 2016-10-24 | 5,774 | $0.00 | 79,478 | No | 4 | C | Indirect | Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | P | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
| No | 4 | C | Indirect | Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Preferred Shares | Disposition | 2016-10-24 | 437,247 | $0.00 | 437,247 | $0.00 |
| Common Stock | Series A-1 Preferred Shares | Disposition | 2016-10-24 | 2,754 | $0.00 | 2,754 | $0.00 |
| Common Stock | Series A-2 Preferred Shares | Disposition | 2016-10-24 | 3,100,477 | $0.00 | 3,100,477 | $0.00 |
| Common Stock | Series A-2 Preferred Shares | Disposition | 2016-10-24 | 19,524 | $0.00 | 19,524 | $0.00 |
| Common Stock | Series A-3 Preferred Shares | Disposition | 2016-10-24 | 2,210,417 | $0.00 | 2,210,417 | $0.00 |
| Common Stock | Series A-3 Preferred Shares | Disposition | 2016-10-24 | 66,490 | $0.00 | 66,490 | $0.00 |
| Common Stock | Series A-3 Preferred Shares | Disposition | 2016-10-24 | 168,224 | $0.00 | 168,224 | $0.00 |
| Common Stock | Series A-3 Preferred Shares | Disposition | 2016-10-24 | 73,704 | $0.00 | 73,704 | $0.00 |
| Common Stock | Series B Preferred Shares | Disposition | 2016-10-24 | 231,077 | $0.00 | 231,077 | $0.00 |
| Common Stock | Series B Preferred Shares | Disposition | 2016-10-24 | 1,454 | $0.00 | 1,454 | $0.00 |
| Common Stock | Series B Preferred Shares | Disposition | 2016-10-24 | 173,167 | $0.00 | 173,167 | $0.00 |
| Common Stock | Series B Preferred Shares | Disposition | 2016-10-24 | 5,210 | $0.00 | 5,210 | $0.00 |
| Common Stock | Series B Preferred Shares | Disposition | 2016-10-24 | 13,180 | $0.00 | 13,180 | $0.00 |
| Common Stock | Series B Preferred Shares | Disposition | 2016-10-24 | 5,774 | $0.00 | 5,774 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016.
- These securities are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VVC IV, except to the extent of its pecuniary interests therein.
- These securities are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VSF IV, except to the extent of its pecuniary interests therein.
- These securities are held of record by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VVC V, except to the extent of its pecuniary interests therein.
- These securities are held of record by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VAF V, except to the extent of its pecuniary interests therein.
- These securities are held of record by Versant Venture Capital V (Canada) LP ("VVC CAN"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN") and VV V CAN is the sole general partner of VVC CAN. VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities, however, each disclaim beneficial ownership of the securities held by VVC CAN, except to the extent of their pecuniary interests therein.
- These securities are held of record by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"). VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interests therein.
Billionaire Hedge Funds
